Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
about
TP53/MicroRNA Interplay in Hepatocellular CarcinomaCirculating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System CancersRecent advances in hepatocellular carcinoma therapy.Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors.BAP1 dependent expression of long non-coding RNA NEAT-1 contributes to sensitivity to gemcitabine in cholangiocarcinomaSerum microRNA panel for early diagnosis of the onset of hepatocellular carcinomaExosomes: small vesicles with big roles in hepatocellular carcinoma.Functional Roles and Therapeutic Applications of Exosomes in Hepatocellular Carcinoma.MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.The function of miR-519d in cell migration, invasion, and proliferation suggests a role in early placentation.Extracellular vesicles in liver diseases.Biomarkers in hepatocellular carcinoma: an overview.Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma.MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination-what we learned from microRNA-494.Diagnostic and prognostic potential of serum microRNA-4651 for patients with hepatocellular carcinoma related to aflatoxin B1.Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis.Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics.Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma.Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).Differential micro ribonucleic acid expression profiling in ovarian endometrioma with leuprolide acetate treatment.Therapeutic effects of serum extracellular vesicles in liver fibrosis.The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies.Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.The Role of MicroRNAs in Hepatocellular CarcinomaLncRNAs as novel players in hepatocellular carcinoma recurrence
P2860
Q28073980-E249E421-7179-4099-987F-949B729369FFQ28080153-D69B4CB6-9BD7-46F2-BAB5-B7B58AA1C298Q30236010-068357EC-9C79-489F-B6A6-ADF40CF3BFE0Q33905628-3071C42B-17ED-4D98-8FA3-5D021E723DA7Q37604659-BE1AA574-2C5C-47C7-B165-B2FC02601CD4Q37606333-CBA189E7-1D00-46D1-B667-3E4C940CEBC5Q37645086-E02A9ACC-A2F4-4E2C-9346-278B19D27E1EQ37654423-88650835-7671-4078-BB1F-3D9C5583C111Q37699375-A0F9D4E4-BE68-4AC4-AC99-188D23CB3E10Q38661848-96AEEC0E-6267-4A4B-861B-43A17CB991E0Q39015729-994E679A-75CC-4C28-9B7D-A7B339CA148BQ39063293-F75357D5-175D-4B59-9A59-A0CBED1A9DFFQ39202758-C529976B-D589-4386-A236-E3BC7C0FB0C9Q40699604-4319B054-6D67-441A-BBFF-834D3A28EF3EQ42167341-886E6670-C7A4-4DE6-AE05-2AFAB7349549Q46480547-D2375DCD-C9BA-404A-BF78-0490021589E4Q47419610-98CA920A-6F26-4C92-AD2E-8E52121FA80AQ47594961-4766A1C7-C9D5-4195-8BF5-F7CEC8D8200FQ48185441-AFFE1302-389E-4383-B277-BF35B5D9BC9DQ48300748-52BD9DBB-61B4-428F-81C9-CF37FF0CEE25Q50067800-138CCBA5-A542-4AFE-A5FB-075D08ED4576Q51424746-250FC37A-0AC3-4452-9ACE-454487107352Q54091049-E41E258E-C2B6-455C-ABEE-6BEA18847522Q54998576-441B6FC8-2152-4E57-A28B-E671D87D8445Q55120346-0F83A40C-1CB7-4BA0-A296-5AE20FFABD47Q55285430-0A33D9C4-5F8C-482E-8BEF-913B89BE962CQ55332393-545C16FE-8934-4C0A-8EDF-E99EFDECDBA8Q55378766-1C0698C1-CC78-4B38-9EF3-941DD374BE72Q55506760-D10D6013-2D07-40A3-A681-14A8B7A59714Q57493789-B692F5B1-A4A7-45C5-9BB2-F83977724DF0Q58738641-23BA8C79-0DDD-4B0C-B14F-C9F19DF47A5D
P2860
Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@ast
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@en
type
label
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@ast
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@en
prefLabel
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@ast
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@en
P2093
P2860
P50
P1433
P1476
Circulating microRNAs, miR-939 ...... y Cirrhotic Patients with HCC.
@en
P2093
Alberto Borghi
Clarissa Patrizi
Davide Trerè
Giuseppe F Stefanini
Laura Venerandi
Luigi Bolondi
Marzia Galassi
P2860
P304
P356
10.1371/JOURNAL.PONE.0141448
P407
P50
P577
2015-10-28T00:00:00Z